These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17979859)

  • 1. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.
    Willis AW; Crowner B; Brunstrom JE; Kissel A; Racette BA
    Dev Med Child Neurol; 2007 Nov; 49(11):818-22. PubMed ID: 17979859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy.
    Polak F; Morton R; Ward C; Wallace WA; Doderlein L; Siebel A
    Dev Med Child Neurol; 2002 Aug; 44(8):551-5. PubMed ID: 12206622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
    Franzén M; Hägglund G; Alriksson-Schmidt A
    BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
    Balaban B; Tok F; Tan AK; Matthews DJ
    Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Multilevel Botulinum Toxin A Injection with Integrated Treatment Program on Spasticity Reduction in Non-Ambulatory Young Children with Cerebral Palsy.
    Aydil S; Akpinar FM; Akpinar E; Beng K; Yagmurlu MF
    Med Princ Pract; 2019; 28(4):309-314. PubMed ID: 30840957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications.
    Autti-Rämö I; Larsen A; Taimo A; von Wendt L
    Eur J Neurol; 2001 Nov; 8 Suppl 5():136-44. PubMed ID: 11851742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of botulinum toxin in diminishing lower limbs spasticity in children with diplegic form of cerebral palsy].
    Gugała B; Snela S
    Chir Narzadow Ruchu Ortop Pol; 2011; 76(2):91-5. PubMed ID: 21853909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
    Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
    Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
    Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
    J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of botulinum toxin A lower limb injections in addition to physiotherapy approaches in children with cerebral palsy: A systematic review.
    Yana M; Tutuola F; Westwater-Wood S; Kavlak E
    NeuroRehabilitation; 2019; 44(2):175-189. PubMed ID: 30856126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].
    Xu KS; Yan TB; Mai JN
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy.
    Frascarelli F; Di Rosa G; Bisozzi E; Castelli E; Santilli V
    Eur J Paediatr Neurol; 2011 Jan; 15(1):59-64. PubMed ID: 20493744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of botulinum toxin type A treatment in children with cerebral palsy: Sequential physical changes for 3 months after the injection.
    Matsuda M; Tomita K; Yozu A; Nakayama T; Nakayama J; Ohguro H; Iwasaki N
    Brain Dev; 2018 Jun; 40(6):452-457. PubMed ID: 29510955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy.
    Wesseling M; Kainz H; Hoekstra T; Van Rossom S; Desloovere K; De Groote F; Jonkers I
    Gait Posture; 2020 Oct; 82():54-60. PubMed ID: 32892101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy].
    Klochkova OA; Kurenkov AL; Karimova HM; Namazova-Baranova LS; Memedyarov AM; Kuzenkova LM; Bursagova BI
    Vestn Ross Akad Med Nauk; 2014; (9-10):57-63. PubMed ID: 25816644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.